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Received June 16, 2015; accepted October 20, 2015AbstractBackground: This study aimed to determine the effects of total saponins from Rhizoma Dioscoreae Nipponicae (TS-RDN) on the expression of
vascular endothelial growth factor (VEGF) and angiopoietin (Ang)-2 and Tie-2 (endothelial tyrosine kinase receptor) receptors in the synovium
of rats with rheumatoid arthritis (RA) (collagen-induced arthritis; CIA), and to examine the mechanisms of TS-RDN in alleviating RA.
Methods: The CIA rat model was established and the animals were randomly divided into control, CIA model, TS-RDN, diosgenin, and
tripterygium groups. Fluorescent polymerase chain reaction was performed to detect VEGF expression in the rat knee joint synovium. Addi-
tionally, immunohistochemical assay was used to detect protein expression of Ang-2 and Tie-2 in the rat knee joint synovium.
Results: Expression of VEGF, Ang-2, and Tie-2 in the model group was significantly higher than in the control group ( p < 0.01). After TS-RDN,
tripterygium and diosgenin treatment, VEGF and Ang-2 expression was lower than in the model group ( p < 0.01). However, Tie-2 expression
showed no significant difference. The effects of TS-RDN on VEGF expression were more marked than those of tripterygium and diosgenin
( p < 0.01).
Conclusion: TS-RDN might reduce the expression of VEGF, Ang-2, and Tie-2 in the synovium, thus inhibiting synovial angiogenesis and
playing a therapeutic role in RA.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Rheumatoid arthritis (RA) is a systemic, chronic, autoim-
mune disease characterized by joint inflammation. RA has a
high prevalence worldwide, with the global incidence rate
being 0.5e1.0% and that in Chinese population being 0.4%.Conflicts of interest: The authors declare that they have no conflicts of interest
related to the subject matter or materials discussed in this article.
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1726-4901/Copyright © 2016, the Chinese Medical Association. Published by El
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).RA severely affects patients' quality of life, since it is difficult
to treat and is associated with high morbidity.1 The basic
pathological feature of RA is multiple, chronic, progressive
synovitis of the joints;2e4 however, other body organs and
tissues might also be involved.5,6 Neoangiogenesis has been
observed to be the main underlying cause of synovitis, pannus
growth, bone and cartilage destruction, and osteophyte for-
mation.7e10 A variety of angiogenic factors could lead to
angiogenesis,11 among which vascular endothelial growth
factor (VEGF) plays a crucial role in promoting angiogenesis.
VEGF was found to be closely associated with synovial
angiogenesis in RA,12 promoting angiogenesis during thesevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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vascularization.13 In addition, angiopoietin (Ang) was corre-
lated with angiogenesis. Tie-2, a co-receptor of Ang, is a
tyrosine kinase receptor that is specifically expressed in
endothelial cells and certain hematopoietic progenitor cells,
and plays an important role in vascular development.14 Among
the Ang family members, Ang-2 can promote angiogenesis,
vascular remodeling, and vascular regression.15 Ang-2 has
VEGF-dependent actions: in the presence of VEGF, it pro-
motes vascular sprouting, whereas in VEGF-deficient condi-
tions, Ang-2 promotes vascular regression.16 Therefore, the
VEGF/VEGF receptor pathway17 and the Ang/Tie-2 (endo-
thelial tyrosine kinase receptor) signaling pathway have
become the focus of RA angiogenesis research.
Our previous research suggested that total saponins from
Rhizoma Dioscoreae Nipponicae (TS-RDN) inhibit neo-
angiogenesis and synovial VEGF expression.18
This study examined the expression levels of synovial
VEGF, Ang-2, and Tie-2, aiming to explore the roles of VEGF
and Ang/Tie-2 signaling pathways in synovial angiogenesis in
a collagen-induced arthritis (CIA) model to ascertain whether
they had synergistic effects. We further aimed to investigate
the mechanisms of TS-RDN in inhibiting synovial angiogen-
esis in a CIA model, to provide experimental evidence for the
use of TS-RDN in RA treatment.
2. Methods2.1. Model preparationSixty female Wistar rats, clean grade, weighing
140 ± 20 g, were purchased from Beijing Vital River Lab-
oratory Animal Technology Co., Beijing. China (Certificate
Number: 0158513), and the CIA model was established as
described previously.19 This study was carried out in strict
accordance with the recommendations noted in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes of Health. The animal use protocol has been
reviewed and approved by the Institutional Animal Care and
Use Committee of Chengde Medical College, Hebei, China.
Bovine type II collagen dissolved in acetic acid (2 mg/mL;
Chondrex, Redmond, WA, USA, Lot Number: 200202) and
Freund's complete adjuvant (Sigma-Aldrich Corp., St. Louis,
MO, USA, Lot Number: 9007-81-2) were mixed in equal
volume and emulsified to form type II collagen emulsion.
Under sterile conditions, the above emulsion was injected
into multiple points on the back and tail root of rats (0.2 mL
at each point); the same dose was re-injected on Day 7 for
potentiation of excitation. The arthritis index (AI) was used
as the standard to evaluate whether the model succeeded or
failed.20 The limb joint swelling was scored on a scale of
0eIV; 0: no swelling; I: slight swelling in toe joint; II:
swelling in toe joint and foot toe joint; III: swelling in paws
under ankle joint; and IV: swelling in all paws, including the
ankle joint. AI value was the sum of swelling scores of four
limbs joints [0, 1, 2, 3, and 4 points for, Grade 0, I II, III, and
IV, respectively (the total score was 16 points]. An AIvalue  4 points indicated successful establishment of the
model.2.2. Animal grouping and treatmentOf the 60Wistar rats, 12were randomlyassigned to the normal
control group. Saline (0.2 mL) was injected into multiple points
on the back and tail root of rats in the normal control group.ACIA
model was successfully established using the remaining 48 rats,
and these rats were randomly divided into the CIA model group
(CIA group), RDN group (extracted by the Traditional Chinese
Medicine Institute of Chengde Medical College), the triptery-
gium (TP) group (Huangshi Feiyun Pharmaceutical Co. Ltd.,
Huangshi, China), and diosgenin (DS) group (Nanjing Zelang
Medical Technology Co. Ltd., Nanjing, China), with 12 rats in
each group. Fourteen days post-modeling, according to the
dosage we confirmed in the preliminary experiment,21 the RDN,
TP, and DS groups were intragastrically administered triptery-
gium glycoside tablet (12 mg/kg/d), TS-RDN (25 mg/kg/d), and
diosgenin (50mg/kg/d), respectively, whereas the control and the
CIA model group were intragastrically administered double
distilled water at 1 mL/100 g body weight. The period during
which medication was administered for each group was 21 days.
The preparation and quality control of TS-RDN were car-
ried out as follows: diosgenin (China Institute of Drug and
Biological Products, Beijing, China; Number: 111539) was
dissolved in methyl alcohol to a final concentration of 0.5 mg/
mL and was used as control.
RDN (1 g) was dissolved in methyl alcohol (50 mL) with
ultrasonic processing (250 W, 33 kHz, 30 minutes), filtered,
and the residue was collected, washed with methyl alcohol
(20 mL), evaporated to remove methyl alcohol, and the
resulting precipitate was dissolved in hydrochloric acid
(3 mol/L), 20 mL, 10 mL, 5 mL, and 5 mL. The solution was
transferred to a conical flask, heated in water bath (30 mi-
nutes), and the sample was refluxed twice with trichloro-
methane in a water bath, with another washing of the
container. The resulting solute was dissolved with methyl
alcohol to 25 mL.
TS-RDN was extracted, refluxed 10 times and eight times
with ethyl alcohol (50%) at 85C for 1 hour, and the filter
liquor was collected for spray drying to obtain TS-RDN.
Reversed-phase high-performance liquid chromatography
was used to test the TS-RDN (Fig. 1).2.3. Sampling treatmentThe rats in each group were killed after peritoneal venous
blood sampling, and the joint synovium of six rats in each group
was sampled (in the DS group, sampling was performed in rats
administered 50 mg/kg/d DS), followed by fixation in 4%
paraformaldehyde solution, gradual alcohol dehydration, xylene
hyalinization, paraffin embedding (automatic dryer and embed-
ding machine; Thermo Fisher Scientific Inc., Waltham, MA,
USA), slicing (Leica paraffin slicing machine; Leica Camera
AG, Solms, Germany), and immunohistochemical staining. The
joint synovium of the remaining six rats in each group was
Fig. 1. Reversed-phase high-performance liquid chromatography. 1: RDN; 2: control; 3: TS-RDN; 4: solution. TS-RDN ¼ total saponins from Rhizoma Dioscreae
Nipponicae.
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rats treated with 25 mg/kg/d DS), placed in Eppendorf tubes, and
immediately stored in liquid nitrogen.2.4. Immunohistochemical staining and image analysisStaining was performed according to the instructions of the
streptavidin-peroxidase immunohistochemical staining kit
(Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd.,
Beijing, China). Rabbit anti-Ang-2 polyclonal primary anti-
body (Abcam, Cambridge, MA, USA, Lot: ab65835) was
diluted to 1:250 and the rabbit anti-Tie-2 polyclonal primary
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA,
Lot: sc-9026) was diluted to 1:50. Phosphate-buffered saline
was used instead of the primary antibody as the negative
control. The MiVnt image analysis system (Shandong Echung
Electronics Co., Ltd., Jinan, Shandong, China) was used to
quantitatively analyze immunohistochemical results at 400-
fold magnification, and the ratio of immunohistochemical-
positive products to the vision field was recorded as theTable 1








GADPH ¼ glyceraldehyde-3-phosphate-dehydrogenase; VEGF ¼ vascular endothrelative expression level of the target protein. Six slices were
selected for each rat and each slice was observed across three
visual fields for the final average value. Two investigators
blinded to group allocation performed image analysis, and the
average value was used.2.5. Real-time polymerase chain reactionTotal RNAwas extracted from the synovial tissues stored in
liquid nitrogen using the Trizol method (Invitrogen, Carlsbad,
CA, USA), and UV-visible spectrophotometer (DU800)
(Beckman Coulter Inc., Brea, CA, USA) was used to detect
the RNA purity and concentration. The sample with good
purity was then used for reverse transcription reaction (RT
master Mix, TaKaRa Biotechnology (Dalian) Co., Ltd.,
Dalian, Liaoning, China, Lot number: DRR036s). The poly-
merase chain reaction (PCR) mixture (10 mL) consisted of
0.5 mg total RNA template and 2 mL 5  PrimeScript RT
Master Mix, diluted up to 10 mL with diethypyrocarbonate
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future use.
The primers and probes of VEGF and of GAPDH were
synthesized by Takara (primer sequences are shown in Table
1). The PCR mixture (25 mL; Taq DNA polymerase;
TaKaRa Biotechnology (Dalian) Co., Ltd., Dalian, Liaoning,
China; DRR039s) consisted of 12.5 mL Taq enzyme, 0.5 mL
upstream and downstream primers (both 10mМ), 1 mL 3mМ
fluorescent probe, and 2 mL template (cDNA), diluted up to
25 mL with diethypyrocarbonate water. The reaction condi-
tions were 40 cycles of denaturation at 95C for 60 seconds,
95C for 10 seconds, and 6C for 30 seconds. SLAN fluo-
rescence quantitative PCR detection system (Shanghai Hon-
gshi Medical Technology Co. Ltd., Shanghai, China) was used
to read the fluorescence at 60C. The fluorescence intensity of
each sample was read three times and averaged. Based on the
Ct value of obtained target gene to that of the internal refer-
ence gene (the Ct value corresponded to the cycle number at
which the fluorescence signal of each reaction well reached
the preset threshold), the internal reference was used for the
normalization process. Relative quantitative analysis of gene
expression was performed in accordance with the 2DDCt
method where 2DDCt represented the relative expression of
the target gene.4 DDCt was calculated according to the
following formula:
DDCt¼ (average Ct value of target gene in the test
group  average Ct value of internal reference gene in the test
group)  (average Ct value of target gene in the control
group  average Ct value of internal reference gene in the
control group).
The experimental data were then analyzed.2.6. Statistical analysisSPSS version 11.5 package (SPSS Inc., Chicago, IL, USA)
was used for statistical analysis. All data were expressed as
mean ± standard deviation. The intergroup comparison was
performed with analysis of variance and pairwise comparison
was performed using the q test, with a ¼ 0.01 set as the
significance.Table 2
Thickness of paw pad, volume of paw and AI score.





Control 3.25 ± 0.30 1.24 ± 0.86 e
Model 6.69 ± 0.29* 2.61 ± 0.15* 7.87 ± 0.52*
Tripterygium 5.43 ± 0.26*,** 2.78 ± 0.12*,** 6.42 ± 0.24*,**
TS-RDN 5.37 ± 0.19*,** 2.69 ± 0.11*,** 6.43 ± 0.23*,**
Diosgenin 5.50 ± 0.19*,** 3.20 ± 0.08*,** 6.40 ± 0.13*,**
Results are presented as mean ± standard deviation.
* p < 0.01 compared with control group.
** p < 0.01 compared with model group.
AI ¼ Arthritis Index; TS-RDN ¼ total saponins from Rhizoma Dioscreae
Nipponicae.3. Results3.1. Clinical manifestations in paws of ratsAfter the first immunization, multiple small lesions were
observed on the back and tail of rats, which had lustrous coats.
On Day 12, the paws were swollen with redness over the
limbs, including the knee joint. The swelling was severe in the
CIA model group and caused limb deformities, subsequently
impairing locomotion. By contrast, in the other groups (except
for the control group), swelling and redness were alleviated;
no significant changes were observed in the control group. The
thickness of the paw pad, hind paw volume, and AI score
increased significantly in the model group compared to that in
the control group ( p < 0.01, Table 2).3.2. Protein expression of Ang-2 in synovial tissuesAs shown in Fig. 2A, Ang-2-postive staining was observed
as yellow or brown granules, which was mainly observed in
the cytoplasm, with slight expression in the nucleus. As shown
in Fig. 2B, compared with the control group, the CIA model
group was characterized by thickened synovial tissues, infil-
tration of inflammatory cells, and a 45-fold increase in protein
expression of Ang-2 ( p < 0.01). Compared with that in the
CIA model group, the protein expression of Ang-2 in the
RDN, TP, and DS groups significantly decreased by 76.7%,
71.7%, and 59%, respectively ( p < 0.01); however, the dif-
ference was not significant among the treatment groups
( p > 0.05).3.3. Protein expression of Tie-2 in synovial tissuesAs shown in Fig. 3A, Tie-2-positive staining was observed
as yellow or brown granules, which were mainly located in the
cytoplasm or on the membrane. As shown in Fig. 3B,
compared with the control group, the CIA model group was
characterized by thickened synovial tissues and infiltration of
inflammatory cells. The protein expression of Tie-2 increased
by 29.75-fold ( p < 0.01) compared to that in the control
group. Compared with the CIA model group, protein expres-
sion of Tie-2 in the RDN, TP, and DS groups decreased;
however, the difference was not significant among the treat-
ment groups ( p > 0.05).3.4. mRNA expression of VEGF in synovial tissuesFluorescence intensity curves were generated (Fig. 4A).
The real-time PCR products were analyzed using 2% agarose
gel electrophoresis (Fig. 4B) and two gene bands were
observed at 134 bp and 87 bp. Expression of VEGF target
gene in the CIA model group increased by 43.48% compared
to that in the control group (Fig. 5; p < 0.01). Compared with
the CIA model group, expression of VEGF target gene in the
RDN, TP, and DS groups decreased significantly ( p < 0.01) by
59%, 32.67%, and 29%, respectively. Expression of VEGF
target gene in the RDN group decreased by 39% and 42.27%,
Fig. 2. (A) Expression of Ang-2 in synovial membrane of rats in each group (400). (1) Normal control group; (2) CIA model group; (3) TS-RDN group
(25 mg/kg/d); (4) tripterygium group (12 mg/kg/d); (5) diosgenin group (50 mg/kg/d). (B) Expression of Ang-2 protein is significantly higher in the synovium of
rats in the CIA model group, compared with the normal control group. Values are expressed as mean ± SD. * p < 0.01; expression of Ang-2 protein is significantly
reduced in synovium of rats in the TS-RDN, tripterygium and diosgenin groups compared with the CIA model group. ** p < 0.01; expression of Ang-2 protein is
similar in the TS-RDN, tripterygium and diosgenin groups. Ang-2 ¼ angiopoietin-2; CIA ¼ collagen-induced arthritis; SD ¼ standard deviation; TS-RDN ¼ total
saponins from Rhizoma Dioscreae Nipponicae.
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( p < 0.05).
4. Discussion
RA is a systemic inflammatory disease that involves mul-
tiple joints of the body, and the main pathological feature is
synovitis. RA is associated with tumor-like growth charac-
teristics such as proliferation of synovial cells, hypertrophy of
synovial tissues, infiltration of inflammatory cells, neo-
vascularization, pannus formation, and fibrotic changes. While
the etiology and pathogenesis of RA are unknown, angio-
genesis has been suggested to play an important role in the
early synovial hyperplastic course of RA, and some studies
have shown that the numbers of synovial neovessels is posi-
tively correlated with the AI integration. Expression of syno-
vial VEGF is positively correlated with the number of
neovessels, indicating that VEGF plays an important role in
the progression of synovitis.22 The VEGF family comprisesVEGFA, VEGFB, VEGFC and VEGFD, and their receptors
Flt-1, KDR, Flt-4, and NRP-1. VEGFs, along with their re-
ceptors, promote the migration of endothelial cells and in-
crease the permeability of the endothelial barrier, thereby
initiating and maintaining angiogenesis.23 VEGF induces
chemokine production by endothelial cells; chemokines attract
the mononuclear cells to invade and release inflammatory
cytokines such as tumor necrosis factor-a and interleukin (IL)-
6. The interactions among the cytokines further increase the
vascular permeability as well as the expression of adhesion
factors, enhancing the migration of inflammatory cells towards
the inflammation sites, thereby prolonging inflammation.24
Agents that block expression of VEGF or interfere with the
VEGF signal transduction pathway could inhibit angiogenesis
and control progression of RA.25 This study also demonstrated
that expression of VEGF in the synovial tissues of the CIA
model group was significantly higher than that in the normal
group, which confirmed that VEGF had an important role in
the pathogenesis of RA.
Fig. 3. (A) Expression of Tie-2 in synovial membrane of rats in each group (400). (1) Normal control group; (2) CIA model group; (3) TS-RDA group (25 mg/kg/
d); (4) tripterygium group (12 mg/kg/d); and (5) diosgenin group (50 mg/kg/d). (B) Expression of Tie-2 protein is significantly higher in synovium of rats in the
CIA model group, compared with normal control group. Values are expressed as mean ± standard deviation. * p < 0.01; expression of Tie-2 protein is similar in the
TS-RDA, tripterygium, diosgenin and CIA model groups. CIA ¼ collagen-induced arthritis; Tie-2 ¼ endothelial tyrosine kinase receptor; TS-RDN ¼ total
saponins from Rhizoma Dioscreae Nipponicae.
Fig. 4. (A) Amplification curve of VEGF and GAPDH. 1 and 6 normal control group; 2 and 7 CIA model group; 3 and 8 total saponins from Rhizoma Dioscreae
Nipponicae group (25 mg/kg/d); 4 and 9 tripterygium group (12 mg/kg/d); and 5 and 10 diosgenin group (50 mg/kg/d). (B) Gel electrophoresis of real-time
quantitative reverse transcriptase polymerase chain reaction products. 1e3: GAPDH gene, 4e6: VEGF gene. GAPDH ¼ glyceraldehyde-3-phosphate-dehydro-
genase; VEGF ¼ vascular endothelial growth factor.
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Fig. 5. Expression of VEGF mRNA is significantly higher in synovium in CIA
model group, compared with normal control group. Values are expressed as
mean ± SD. * p < 0.01; expression of VEGF mRNA is significantly reduced in
synovium in the TS-RDN (25 mg/kg/d), tripterygium (12 mg/kg/d) and dio-
sgenin (50 mg/kg/d) compared with CIA model groups. ** p < 0.01;
expression of VEGF mRNA is higher in the tripterygium and diosgenin groups
compared with TS-RDN group. *** p < 0.05; expression of VEGF mRNA is
similar in the tripterygium and diosgenin groups. CIA ¼ collagen-induced
arthritis; SD ¼ standard deviation; TS-RDN ¼ total saponins from Rhizoma
Dioscreae Nipponicae; VEGF ¼ vascular endothelial growth factor.
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RA. The Ang family comprises Ang-1, Ang-2, Ang-3, and
Ang-4. Ang-1 and Ang-2 are related to angiogenesis. Ang1
and Tie-2 interact with each other to promote autophosphor-
ylation of the receptor (activation). Endothelial cells express-
ing activated Tie-2 attract vascular smooth muscle cells,
pericytes, and other perivascular cells towards the vascular
endothelial cells to form a complete vascular wall, thereby
promoting vascular remodeling and maturation, maintaining
vascular integrity, and regulating vascular functions. In addi-
tion, the effects of Ang-2 on angiogenesis are related to the
local microenvironment; in the presence of VEGF and other
angiogenic factors, Ang-2 competitively inhibits Ang-1, pro-
moting neoangiogenesis, vascular remodeling, and formation
of new capillaries. When the local microenvironment lacks
these factors, Ang-2 inhibits Ang-1, contributing to vascular
regression.26 VEGF, Ang-1 and Ang-2 possibly interact syn-
ergistically, thus mediating the synovial thickening and pannus
formation observed in RA. Therefore, VEGF, Ang-1, and Ang-
2 are considered to be important factors in the occurrence and
development of synovitis.16 This study evaluated the expres-
sions of VEGF and Ang-2 in the synovial tissues of CIA
model rats and found that they might act synergistically in the
pathological process of RA synovitis.
Recently, many studies have reported that tripterygium
decreases expression of VEGF in the synovial tissues of CIA
rats, thus inhibiting angiogenesis.27 Therefore, tripterygium
glycosides were used as the positive control in this study. TS-
RDN is an active ingredient isolated from the dried roots of
RDN, which has anti-inflammatory and immunosuppressive
effects and therapeutic effects in rat models of adjuvant
arthritis. Previous study has shown that TS-RDN inhibits
expression of IL-1/IL-6/IL-8/tumor necrosis factor-a in serum
and synovial fluid of adjuvant-induced arthritis and CIA.28 In
addition, TS-RDN inhibits T cell lymphopoiesis as well as IL-2 expression in vitro.29 It also inhibits nuclear factor-kB p65/
signal transducer and activator of transcription 3/activator
protein-1 and VEGF expression.30,31
Previous study32 used conventional reverse transcriptase
PCR, which was not a reliable quantitation method owing to
large variability. In the present study, real-time fluorescence
quantitative PCR was used for analysis of VEGF mRNA
expression in rat synovium, and showed that TS-RDN, trip-
terygium and diosgenin decreased VEGF mRNA expression in
the synovial tissues of the CIA rat model. TS-RDN had better
effects than tripterygium and diosgenin. TS-RDN contained
fat-soluble and water-soluble saponins. Diosgenin is a fat-
soluble saponin. The results showed that TS-RDN exhibited
better inhibitory effects against VEGF mRNA expression than
diosgenin did, suggesting that in addition to the fat-soluble
saponins, the water-soluble saponins in TS-RDN were
involved in inhibiting the progression of RA. Immunohisto-
chemical staining was performed to detect Ang-2 and Tie-2 in
the synovial tissues, and showed that TS-RDN, tripterygium
and diosgenin decreased the expression of Ang-2 and Tie-2 in
the synovial tissues of the CIA rat model. These results sug-
gest that TS-RDN blocks synovial angiogenesis by inhibiting
VEGF and Ang/Tie-2 expression and their synergistic inter-
action and by reducing the reactivity of vascular endothelial
cells toward the angiogenesis factors. This study has provided
an experimental evidence for application of TS-RDN to
treatment of RA.
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